Skip to main content

Latest Insights

Charles Hepworth Blog
EU inflation falls to 2.4% in November
30 November 2023

Lower-than-expected EU CPI fuels speculation of interest rate cuts next year.

Investment Opinions
The Disruptive Strategist: The rise of GLP-1 weight loss drugs
30 November 2023

GLP-1 weight loss drugs are transforming the healthcare scene. Some analysts are predicting that the anti-obesity market may become the largest pharmaceutical market in history, while on the other hand, share prices of medical device companies, particularly those specialising in diabetes and obesity management, are beginning to feel the pressure.

Charles Hepworth Blog
US Q3 GDP revised up to 5.2%
29 November 2023

Higher business investment and government spending lift growth to a level likely to worry policymakers, albeit consensus still says rates have peaked.